Conestoga Discovery Fund Institutional Class CMIRX

Medalist Rating as of | See Conestoga Investment Hub
  • NAV / 1-Day Return 9.66  /  −0.31 %
  • Total Assets 5.2M
  • Adj. Expense Ratio
    1.250%
  • Expense Ratio 1.250%
  • Distribution Fee Level High
  • Share Class Type Institutional
  • Category Small Growth
  • Investment Style Small Growth
  • Min. Initial Investment 250,000
  • Status Open
  • TTM Yield 0.00
  • Turnover 31%

USD | NAV as of Jun 08, 2026 | 1-Day Return as of Jun 08, 2026, 10:45 PM GMT+0

Morningstar’s Analysis CMIRX

Will CMIRX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Conestoga Discovery Institutional holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings CMIRX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 45.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Twist Bioscience Corp

6.29 322,936
Healthcare

Mama's Creations Inc Common Stock

5.05 259,393
Consumer Defensive

Palomar Holdings Inc

4.72 242,686
Financial Services

Electrovaya Inc

4.60 236,408
Industrials

Vericel Corp

4.59 235,956
Healthcare

Digi International Inc

4.55 233,687
Technology

Transcat Inc

4.29 220,310
Industrials

Universal Technical Institute Inc

3.93 201,724
Consumer Defensive

Bowman Consulting Group Ltd

3.92 201,511
Industrials

Graham Corp

3.84 197,064
Industrials

Sponsor Center